← Eichor
Condition: Dna Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Dna

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Local Hyperthermia Combined With Topical 3% Hydrogen Peroxide for Refractory Viral Warts
NA · 2 location(s) · First Hospital of China Medical University · NCT07565350
Trifecta-Kidney cfDNA-MMDx Study
Phase N/A · 31 location(s) · University of Alberta · NCT04239703
Blood Tuberculosis DNA Levels to Monitor Tuberculosis Treatment
Phase N/A · 1 location(s) · University of Oxford · NCT06845618
Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase 1/Phase 2 · 2 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT06648096
A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After NAC in TNBC
Phase 2 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT04501523
ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases
Phase N/A · 16 location(s) · GERCOR - Multidisciplinary Oncology Cooperative Group · NCT05787197
ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC
Phase N/A · 1 location(s) · Fang Wu · NCT05198154
Pegylated Interferon α in Previously Interferon-treated CHB(Leading Study)
NA · 1 location(s) · Qing XIe · NCT06323681
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Re
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT02610439
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Te
Phase 2 · 48 location(s) · AbbVie · NCT07023289
The Establishment of Korean Hepatitis B Patients Cohort
Phase N/A · 1 location(s) · Yonsei University · NCT04139850
RESPONSE: Colorectal Cancer Survivors' Follow-up Care - Now Digital and Need-based
NA · 9 location(s) · University of Aarhus · NCT06614647
Poor Sleep During Pregnancy as Risk Factor for Post-partum Stress and Mental Health
NA · 2 location(s) · University of Rome G. Marconi · NCT06379074
Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
NA · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT07025785
Sweden Cancerome Analysis Network - Breast Recurrence (SCAN-B-rec)
Phase N/A · 2 location(s) · Lund University Hospital · NCT03758976
HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia
Phase 1 · 2 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT04131413
European Project for ctDNA Detection as a Biomarker for Non-invasive Therapy Monitoring in Paediatric Classical Hodgkin
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07356882
In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT07239323
The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer
NA · 4 location(s) · Thomas Jefferson University · NCT05502523
Sequential PEG-IFN for HBV After Ending RNA-targeted Regimens
NA · 2 location(s) · Huashan Hospital · NCT06923280
Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy
Phase 2 · 1 location(s) · Vanderbilt-Ingram Cancer Center · NCT05770531
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced
Phase 2/Phase 3 · 18 location(s) · TuHURA Biosciences, Inc. · NCT06947928
Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer
Phase N/A · 1 location(s) · Julia Foldi · NCT06666439
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Phase 3 · 1 location(s) · Shanghai Bovax Biotechnology Co., Ltd. · NCT04422366
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Phase N/A · 24 location(s) · Mayo Clinic · NCT05051722
Comparison of TAF and TDF in Preventing Mother-to-Child Transmission of HBV in Pregnancies With High Viral Loads
NA · 10 location(s) · Guangzhou 8th People's Hospital · NCT06947356
Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic Leukemia
EARLY_Phase 1 · 1 location(s) · Zhejiang University · NCT06793241
Combined Use of Bacteroides Fragilis and BCAAs on HBsAg Clearance
Phase N/A · 1 location(s) · First Affiliated Hospital of Fujian Medical University · NCT07257562
GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Colorectal Cancer
Phase N/A · 15 location(s) · Claus Lindbjerg Andersen · NCT06111105
Videocapsule Endoscopy in Lynch Syndrome
NA · 1 location(s) · San Raffaele University · NCT05704010
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.